Law firms

Disputes round-up: Supreme Court loss for Pfizer as Mishcon’s Levitt QC returns to the Bar

Disputes round-up: Supreme Court loss for Pfizer as Mishcon’s Levitt QC returns to the Bar

Allen & Overy (A&O) client Pfizer has lost a landmark Supreme Court battle against a host of manufacturers, leaving it vulnerable to substantial financial claims.

In a judgment handed down yesterday (14 November), the Supreme Court upheld lower court decisions that Pfizer’s patent for its pregabalin pain relief product was invalid. Branded as ‘Lyrica’, the pregabalin-based drug is used to treat neuropathic pain as well as generalised anxiety disorder and epilepsy.

This article is for Legal Business subscribers. Please log in or subscribe to read on.